Corellation of Mutations, TILs and Age in Breast Cancer
NCT04033965 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 345
Last updated 2019-07-26
Summary
Age may pertain to different tumor genotype characteristics which may interfere with treatment efficacy and prognosis. The investigators investigated the distribution and prognostic effect of mutations (mut) and tumor infiltrating lymphocyte (TILs) in young and elderly early breast cancer patients (pts).
Conditions
Interventions
- GENETIC
-
Corellation of Mutations, TILs and Age in Breast Cancer
Sponsors & Collaborators
-
Hellenic Cooperative Oncology Group
lead OTHER
Principal Investigators
-
Adamantia Nikolaidi, MD · Oncology Department, MITERA Hospital
Eligibility
- Min Age
- 18 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 1997-09-03
- Primary Completion
- 2010-10-01
- Completion
- 2010-10-01
More Related Trials
-
Adjuvant Treatment in Premenopausal Breast Cancer
NCT06807749 ·Status: NOT_YET_RECRUITING
-
Tracking Triple-negative Breast Cancer Evolution Through Therapy
NCT03077776 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Protocol to Examine Methylation of Tumor Suppression Genes in Women at High Risk of Developing Breast Cancer
NCT00323908 ·Status: COMPLETED
-
Breast Imaging Studies in Women at High Genetic Risk of Breast Cancer: Menstrual Cycle Study
NCT00006425 ·Status: COMPLETED
-
Genetic Predisposition to Breast and Ovarian Cancer: Prospective Study of BRCAx Gene Mutation
NCT03667417 ·Status: RECRUITING
-
Breast Cancer Risk Assessment in Women Aged 40-49
NCT03180086 ·Status: COMPLETED ·Phase: NA
-
A Novel Approach Utilizing Organ Specific Age Proteomics
NCT06789653 ·Status: RECRUITING
-
Susceptibility to Breast Cancer
NCT00004565 ·Status: COMPLETED
-
A Study Comparing the Differences Between Young and Non-young Breast Cancer
NCT06793306 ·Status: ENROLLING_BY_INVITATION
-
Genetic and Protein Profiling in Normal and Cancerous Breast Tissue
NCT00083733 ·Status: COMPLETED
-
Genotype and Phenotype in Early Onset Breast Cancer in Young Women on the Two Shores of the Mediterranean Sea
NCT02541188 ·Status: TERMINATED
-
Blood Test for Early Detection of Breast Cancer Using Todos Medical -Breast 1(TM-B1) Assay
NCT03343691 ·Status: UNKNOWN
-
Correlation of Molecular Markers With Response to Therapy and Breast Cancer Behavior
NCT01000883 ·Status: RECRUITING
-
The Value of Geriatric Assessments in Older Patients With Breast Cancer
NCT03640117 ·Status: UNKNOWN
-
21-gene in Elder Breast Cancer Patients With Lymph Node Metastasis
NCT06891651 ·Status: RECRUITING
-
Understanding Decision Making Processes for Undergoing Genetic Testing Among Women With Newly Diagnosed Breast Cancer
NCT01386411 ·Status: COMPLETED
-
Cellular Immune Responses in Triple-negative Breast Cancer - High Throughput Immunogenetic Studies
NCT06646263 ·Status: ENROLLING_BY_INVITATION
-
Research for Predictive Biologic Parameters of Cutaneous Hypersensitivity After Brachytherapy in Breast Cancer
NCT00922961 ·Status: COMPLETED ·Phase: NA
-
Biomarkers in Predicting Response to Tamoxifen and Letrozole in Postmenopausal Women With Primary Breast Cancer Treated on Clinical Trial CAN-NCIC-MA17
NCT00897065 ·Status: UNKNOWN
-
Studying Breast Cancer Risk in Women Who Are BRCA1/BRCA2 Mutation Carriers
NCT00897455 ·Status: UNKNOWN
-
Breast Cancer Risk in Women Who Are BRCA1/BRCA2 Mutation Carriers
NCT00899145 ·Status: WITHDRAWN
-
Triple-negative Breast Cancer: a New Perspective on Biomarkers
NCT03539965 ·Status: COMPLETED
-
Biomarkers in Patients With Metastatic Breast Cancer
NCT05871788 ·Status: NOT_YET_RECRUITING
-
Cytokine Expression During Radiation for Breast Cancer
NCT00836186 ·Status: COMPLETED ·Phase: NA
-
Use of INnovative and Micro-INvasive TEchniques for the Early Identification of Breast Cancer Patients Benefitting From Neo-adjuvant Therapy
NCT05846997 ·Status: UNKNOWN